How many institutions own ARDS stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ARDS shares is 2, representing 11.44% of the company's common stock.

Who are the major shareholders selling Aridis Pharmaceuticals, Inc. stock?

WEALTH ARCHITECTS, LLC, in the last quarter, reduced its stake in ARDS by -100% restricting it's holding to 0 shares of worth nearly -. GEODE CAPITAL MANAGEMENT, LLC also lessened -100% of the ARDS shares from its portfolio, reducing its holding to 0 shares of worth -. ROUMELL ASSET MANAGEMENT, LLC also shunned ARDS shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying ARDS stock?

As per its latest 13F filing, STRENGTHENING FAMILIES & COMMUNITIES, LLC increased its stake in ARDS by 100% in the last quarter. The institutional holder raised its holding to 3 thousand shares having worth more than $1.00. STRENGTHENING FAMILIES & COMMUNITIES, LLC also added 100% more shares of ARDS to its portfolio, raising its holding to 3 thousand shares of worth $3.00. also increased its ARDS shares holding by 100% which brought its holding to 150 shares worth $10.00.

ARDS's major insiders: who are they?

The insider with the most stakes in ARDS is Truong Vu , CEO at the company. Additionally, ARDS stock is highly held by director Patzer Eric and Chief Medical Officer Jafri Hasan among others.

Did an insider recently sell ARDS stock?

Company executives, directors, and other insiders own N/A percent of Aridis Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ARDS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased ARDS stock?

There have been 0 transaction(s) during the past 6-months in which Aridis Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

How much of ARDS does insiders own?

Around 0 Aridis Pharmaceuticals, Inc. shares are held by insiders, which represents about N/A of ARDS stock.

Who is the insider with the largest stake?

ARDS CEO, Truong Vu holds the largest portfolio of the company's shares. ARDS shares owned by Truong total nearly 1.38 million.

Which institution holds the most shares in ARDS?

STRENGTHENING FAMILIES & COMMUNITIES, LLC is the largest institutional owner in ARDS which holds 3 thousand shares worth $1.00 or 0.01% of the total ARDS shares outstanding followed by STRENGTHENING FAMILIES & COMMUNITIES, LLC with ownership of 3 thousand shares representing 0.01% of the ARDS ownership. is the third largest stakeholder with 150 shares or 0% of the ownership worth more than $10.00.

Is Aridis Pharmaceuticals, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ARDS is concerned, it is a stock which is not optionable.

Is there a short position on ARDS's shares?

Number of ARDS shares short is 2.00M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding ARDS shares are there?

As of today, 44.57M shares of ARDS are outstanding.

Is there many float in ARDS stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ARDS has 40.31M shares in float.

ARDS short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ARDS is 0.22.

Stock Ideas

ARDS Stock Ownership Breakdown

NASDAQ : ARDS

Aridis Pharmaceuticals

$0.00

At Close 4:00 PM

67.09

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares5.55

Short Percent Of Float6.8

Shares Outstanding44.57M

Shares Float40.31M

Shares Short2.00M

Short Ratio0.22

6.8%

Short % of Float

5.55%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

N/A Percentage of Shares held by All Insiders

11.44% Percentage of Shares held by All Institutions

11.44% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 11.44% of ARDS shares are held by financial institutions. STRENGTHENING FAMILIES & COMMUNITIES, LLC is the top corporate investor, holding 3K shares valued at $1.00. A 0.01% stake in Aridis Pharmaceuticals, Inc. is owned by the company. STRENGTHENING FAMILIES & COMMUNITIES, LLC owns 3K shares valued at $3.00, which translates its holding of 0.01% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	STRENGTHENING FAMILIES & COMMUNITIES, LLC	0.01%	3K	1	3K	+100.00%
Sep 30, 2025	STRENGTHENING FAMILIES & COMMUNITIES, LLC	0.01%	3K	3	3K	+100.00%
Dec 31, 2023		0%	150	10	150	+100.00%
Dec 31, 2023	BARTLETT & CO. WEALTH MANAGEMENT LLC	0%	150	10	150	+100.00%
Dec 31, 2023	WEALTH ARCHITECTS, LLC	0%	0	-	-14.08K	-100.00%
Sep 30, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-143.03K	-100.00%
Sep 30, 2023	ROUMELL ASSET MANAGEMENT, LLC	0%	0	-	-446.59K	-100.00%
Sep 30, 2023	BLACKROCK INC.	0%	0	-	-4.61K	-100.00%
Sep 30, 2023	HRT FINANCIAL LP	0%	0	-	-73.72K	-100.00%
Sep 30, 2023	WEALTH ARCHITECTS, LLC	0.04%	14.08K	-	0	0
Sep 30, 2023	VIRTU FINANCIAL LLC	0%	0	-	-11.81K	-100.00%
Sep 30, 2023	VONTOBEL HOLDING LTD.	0%	0	-	-50K	-100.00%
Sep 30, 2023	CORNERSTONE WEALTH MANAGEMENT, LLC	0%	0	-	-20K	-100.00%
Sep 30, 2023	ICA GROUP WEALTH MANAGEMENT, LLC	0%	0	-	-250	-100.00%
Sep 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-16.36K	-100.00%
Sep 30, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-1.46K	-100.00%
Sep 30, 2023	NORTHERN TRUST CORP	0%	0	-	-28.1K	-100.00%
Sep 30, 2023	ACADIAN ASSET MANAGEMENT LLC	0%	0	-	-36.53K	-100.00%
Sep 30, 2023	GROUP ONE TRADING, L.P.	0%	0	-	-2.34K	-100.00%

Insiders

Among the ARDS insiders holding of N/A of the stake in company, TRUONG VU, CEO, holds the largest shares of 1.38M. PATZER ERIC, director, is the second largest ARDS insider with ownership of 884.6K shares. JAFRI HASAN, Chief Medical Officer, stands third with possession of 5K shares of that stake.

Insiders	Designation	Shares Held
TRUONG VU	CEO	1.38M
PATZER ERIC	director	884.6K
JAFRI HASAN	Chief Medical Officer	5K
HAMILTON JOHN F	director	2K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 24, 2024	TRUONG VU	PURCHASE	0.07	714.29K	50K	1.38M
Jun 24, 2024	PATZER ERIC	PURCHASE	0.07	714.29K	50K	884.6K
Sep 07, 2021	JAFRI HASAN	PURCHASE	4.15	1.99K	8.26K	5K
Sep 03, 2021	JAFRI HASAN	PURCHASE	4.15	3.01K	12.49K	3.01K
Jul 27, 2021	HAMILTON JOHN F	PURCHASE	4.87	2K	9.74K	2K
Jul 27, 2021	TRUONG VU	PURCHASE	5.11	5K	25.55K	737.35K
Jul 27, 2021	PATZER ERIC	PURCHASE	4.84	5.18K	25.05K	702.13K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.